Serial #79255825
LIVE

Serial Number

79255825

Owner

Stalicla SA

Attorney

Douglas R. Wolf

Filing Date

Nov 16, 2018

Add to watchlist:

No watchlists yet
View on USPTO

Serial #79255825 Trademark

Serial Number: 79255825 • Registration: 6010188

Serial #79255825 is a trademark filed by Stalicla SA on November 16, 2018. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Stalicla SA (2 trademarks)

Campus Biotech Innovation Park,

Entity Type: 33

Trademark Details

Filing Date

November 16, 2018

Registration Date

March 17, 2020

Published for Opposition

December 31, 2019

Goods & Services

Business consulting; project management services for others for business purposes; compilation and management of databases and central data files in the field of medicine; creation of central data files in the nature of compiling data in the field of medicine other than for research purposes; compilation of statistics; collection and systemization of data in a central file; business information, namely, provision of commercial information in the field of pharmaceutical products and medical and scientific research in the field of pharmaceutical products and clinical trials; data processing services; business data analysis services; statistical and commercial analysis services for biomedical institutions and for medical and medical research institutions for business purposes; statistical and commercial analysis of technical data via computers for business purposes; computerized data processing; statistical and commercial data analysis services in the fields of public health, health care, bio-medicine as well as clinical trials for business purposes; compilation of information into computer databases for research and analysis in the fields of biomedicine and clinical trials

Scientific and technological services, namely, research and design services relating to the development of therapeutic products; therapeutic product development featuring industrial analysis and research services; design and development of computer hardware and software; engineering services featuring technical data analysis services; pharmaceutical and biomedical research services; provision of online, non-downloadable software via a website for analysis in the fields of biomedical research, clinical trial data and clinical trials; provision of a non-downloadable web-based software used to access information in the fields of biomedical research and clinical trials as well as related data; provision of online, non-downloadable software via a database used to access biomedical research and clinical trial data; biomedical research services; provision of scientific research information in the fields of biomedicine and clinical trials; Therapeutic product design development featuring scientific data analysis services; design and development of software; medical research services; database design in the field of medicine

Pharmaceutical and veterinary products, namely, pharmaceutical preparations used to treat autism spectrum disorder and neurological, psychiatric, oncological, and immune system related diseases or disorders; diagnostic medical products for medical use, namely, medical diagnostic reagents, diagnostic agents, preparations and substances for medical purposes; pharmaceutical healthcare preparations used to treat autism spectrum disorder and neurological, psychiatric, oncological, and immune system related diseases or disorders; medicinal preparations and substances, namely, medical diagnostic reagents, diagnostic agents, preparations and substances for medical purposes and pharmaceutical preparations used to treat autism spectrum disorder and neurological, psychiatric, oncological, and immune system related diseases or disorders; biochemical preparations for medical or veterinary used to treat autism spectrum disorder and neurological, psychiatric, oncological, and immune system related diseases or disorders; chemical reagents for medical or veterinary use; biological reagents for medical or veterinary use, namely, biological preparations used to treat autism spectrum disorder and neurological, psychiatric, oncological, and immune system related diseases or disorders; biological preparations for medical use to treat autism spectrum disorder and neurological, psychiatric, oncological, and immune system related diseases or disorders; chemical preparations for medical use to treat autism spectrum disorder and neurological, psychiatric, oncological, and immune system related diseases or disorders; biotechnological preparations in the nature of pharmaceutical preparations for medical use to treat autism spectrum disorder and neurological, psychiatric, oncological, and immune system related diseases or disorders; biotechnological products in the nature of pharmaceutical preparations for medical use to treat autism spectrum disorder and neurological, psychiatric, oncological, and immune system related diseases or disorders; diagnostic preparations for medical use; diagnostic or monitoring biomarker reagents for medical purposes used to treat autism spectrum disorder

Medical services, namely, medical analysis services; provision of information in the fields of medicine, health and health care

Data processing equipment, computing apparatus in the nature of computer hardware; downloadable computer spreadsheet and word processing software for general use; computer systems comprising computer hardware and recorded computer programs for capturing, collecting, converting, analyzing, communicating, processing, receiving, recording, storing and transmitting data, images and information

Filing History

TEAS SECTION 71 & 15 RECEIVED
Mar 16, 2026 ES75
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Mar 17, 2025 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Aug 25, 2020 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Aug 1, 2020 FICS
FINAL DISPOSITION PROCESSED
Aug 1, 2020 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jun 17, 2020 FICR
REGISTERED-PRINCIPAL REGISTER
Mar 17, 2020 R.PR
NOTIFICATION PROCESSED BY IB
Jan 4, 2020 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 31, 2019 NPUB
PUBLISHED FOR OPPOSITION
Dec 31, 2019 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Dec 18, 2019 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Dec 18, 2019 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 11, 2019 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 26, 2019 CNSA
EXAMINER'S AMENDMENT ENTERED
Nov 26, 2019 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 26, 2019 GNEN
EXAMINERS AMENDMENT E-MAILED
Nov 26, 2019 GNEA
EXAMINERS AMENDMENT -WRITTEN
Nov 26, 2019 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 7, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 6, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 6, 2019 TROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 6, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 6, 2019 REAP
CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Oct 29, 2019 CORN
CORRECTION TRANSACTION RECEIVED FROM IB
Sep 12, 2019 CRCV
REFUSAL PROCESSED BY IB
May 25, 2019 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 6, 2019 RFCS
REFUSAL PROCESSED BY MPU
May 6, 2019 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 14, 2019 RFCR
NON-FINAL ACTION WRITTEN
Apr 13, 2019 CNRT
APPLICATION FILING RECEIPT MAILED
Apr 9, 2019 MAFR
ASSIGNED TO EXAMINER
Apr 5, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 5, 2019 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 4, 2019 REPR